Fludarabine Fludara

Fludarabine Fludara

This chemotherapy and cancer drugs article is about Fludarabine (Fludara) which is a type of chemotherapy used in the treatment of chronic lymphocytic leukaemia (CLL), low grade non-Hodgkin’s lymphoma (NHL), hairy cell leukaemia, and a type of lymphoma that affects the skin called mycosis fungoides.  It is an anti-metabolite, which stops cells making and repairing DNA. It is administered intravenously, as an injection or in tablet form.

The Scottish Medicines Consortium has claimed that Fludarabine phosphate has been associated with higher response rates than chlorambucil in clinical trials. No overall survival advantage over other therapies has been demonstrated.

Side effects can include: increased risk of infection, anaemia, bruising and bleeding, fatigue and fever, nausea and vomiting, diarrhoea, temporary loss of periods, neuropathy, eyesight problems, mouth sores and skin rashes.  Fludarabine may cause changes in your immune system that permanently affect the production of blood cells.  

Approved by

the Medical Board. 

Click Here

 

 

 

 

 

 

Other articles that you may find interesting are:

  1. A diet for Chemotherapy
  2. Immunotherapy overview
  3. A to Z Guide to Complementary Therapies

Go to: Return to the CANCERactive drug list

 

Learn about your cancer drugs.
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.